Xtx Topco LTD Replimune Group, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$5.01 - $9.46 $15,881 - $29,988	-3,170 Reduced 17.93%	14,505 $130,000
Q1 2024 May 13, 2024	BUY	$6.87 - $9.31 $121,427 - $164,554	17,675 New	17,675 $144,000
Q3 2023 Nov 13, 2023	BUY	$15.96 - $22.18 $197,696 - $274,743	12,387 New	12,387 $211,000
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $292,859 - $487,373	16,754 Added 214.71%	24,557 $433,000
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $133,353 - $217,781	7,803 New	7,803 $212,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $605M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.